Kontoor Brands, Inc.
Business Overview: Kenvue Inc. (NYSE: KTB)
Executive Summary
Kenvue Inc., spun off from Johnson & Johnson in 2023, describes itself as "the world's largest pure-play consumer health company by revenue." It sells trusted, decades-old over-the-counter health and personal care brands in more than 165 countries, generating $15.1 billion in net sales in fiscal 2025.
Kenvue's story took a major turn on November 2, 2025, when it entered a merger agreement with Kimberly-Clark, approved by Kenvue shareholders on January 29, 2026 and still subject to other closing conditions — meaning Kenvue's independent public-company life may be coming to an end.
1. Core Business Model & How They Work
[ Legacy OTC/Personal Care Brand Portfolio ] ➡️ [ Three Reporting Segments ] ➡️ [ Global Retail & Pharmacy Distribution (165+ Countries) ] ➡️ [ Brand Marketing & Trust ] ➡️ [ Repeat, Non-Discretionary Purchase Behavior ]
Kenvue's moat, to the extent it has one, is built from decades of consumer trust in specific brand names for specific ailments — a different kind of defensibility than patents or network effects, but a real one in categories where consumers default to familiar names during moments of discomfort or illness.
2. Business Segments
┌──────────────────────────────────────────┐
│ Kenvue Inc. │
└─────────────────────┬──────────────────────┘
┌────────────┼────────────┐
▼ ▼ ▼
┌─────────────┐ ┌──────────┐ ┌───────────────┐
│ Self Care │ │ Skin │ │ Essential │
│ │ │ Health & │ │ Health │
│ │ │ Beauty │ │ │
└──────┬───────┘ └────┬─────┘ └───────┬────────┘
│ │ │
Tylenol, Benadryl Neutrogena, Listerine,
Motrin, Zyrtec, Aveeno, BAND-AID,
Nicorette Rogaine, OGX Johnson's, o.b.
- Self Care: cough/cold/allergy, pain care, and other self care (digestive health, smoking cessation, eye care). Key brands: Benadryl, Motrin, Nicorette, Tylenol, Zyrtec.
- Skin Health and Beauty: face/body care and hair/sun/other. Key brands: Aveeno, Lubriderm, Neutrogena, OGX, Rogaine.
- Essential Health: oral care, baby care, and other (women's health, wound care). Key brands: BAND-AID, Johnson's, Listerine, Desitin, o.b.
3. Competitive Landscape
Kenvue names real, specific competitors per segment: in Self Care, Haleon, Procter & Gamble, and Reckitt Benckiser Group (plus private label); in Skin Health and Beauty, Beiersdorf, Estée Lauder, L'Oréal, Procter & Gamble, and Unilever (plus private label); in Essential Health, Church & Dwight, Colgate-Palmolive, Haleon, Kimberly-Clark, and Procter & Gamble (plus private label). Notably, Kimberly-Clark — Kenvue's own named Essential Health competitor — is also the company now acquiring it.
4. Strategic Strengths & Risks
Strengths: iconic, decades-trusted brands (Tylenol, Neutrogena, Listerine, BAND-AID) with real consumer habit formation; global distribution reach across 165+ countries; durable, repeat-purchase demand for health/hygiene categories that are largely non-discretionary.
Risks:
- Pending Kimberly-Clark merger: the most material near-term fact about Kenvue is that it is being acquired, with shareholder approval already secured — independent strategic direction is effectively on hold pending deal close.
- Intense, well-capitalized competition: every segment faces multiple giant, resource-rich rivals (P&G, Unilever, Haleon, L'Oréal) capable of matching marketing spend and innovation.
- Private-label erosion: every segment explicitly cites private-label competition, which has structurally pressured branded consumer-health pricing for years.
5. Summary Conclusion
Kenvue is a real, large-scale consumer health company whose moat is built on some of the most trusted brand names in the category — a genuine, if old-fashioned, form of defensibility. Its current defining fact, however, is the pending Kimberly-Clark acquisition, which makes Kenvue's future less about competitive strategy as a standalone company and more about how its brand portfolio gets integrated into a larger consumer products parent.